BFM
ACIU icon

Boothbay Fund Management’s AC Immune ACIU Stock Holding History

Boothbay Fund Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,046
Closed -$37.9K – 1363
2024
Q4 		$37.9K Buy
+14,046
New +$43.9K ﹤0.01% 1387
2021
Q3 		– Sell
-22,079
Closed -$175K – 1857
2021
Q2 		$175K Buy
22,079
+8,661
+65% +$59.9K 0.01% 1571
2021
Q1 		$102K Buy
+13,418
New +$95.8K ﹤0.01% 1469
2019
Q3 		– Sell
-111,754
Closed -$620K – 750
2019
Q2 		$620K Buy
111,754
+17,288
+18% +$88.1K 0.06% 370
2019
Q1 		$477K Buy
94,466
+70,124
+288% +$446K 0.05% 395
2018
Q4 		$230K Sell
24,342
-15,618
-39% -$147K 0.03% 454
2018
Q3 		$320K Buy
+39,960
New +$402K 0.03% 484

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boothbay Fund Management's ACIU Position: Q1 2025 in Review

Boothbay Fund Management sold out of AC Immune (ACIU) in Q1 2025, closing a stake of 14,046 shares — an estimated $37.9K sold.

Boothbay Fund Management first reported a position in ACIU in Q3 2018 and held it in 7 quarters. The position peaked at $620K in Q2 2019. 41 funds tracked by Wall St. Rank hold ACIU as of Q1 2025.

  • Boothbay Fund Management reported no remaining AC Immune position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 14,046 AC Immune shares in Q1 2025, an estimated $37.9K.
  • Boothbay Fund Management first reported a position in AC Immune in Q3 2018 and held it in 7 quarters.
  • Boothbay Fund Management's AC Immune position peaked at $620K in Q2 2019.
  • 41 funds tracked by Wall St. Rank held AC Immune as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.